Eden Research (LON:EDEN) Stock Price Down 3.3% – Here’s Why

by · The Cerbat Gem

Shares of Eden Research plc (LON:EDEN – Get Free Report) were down 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The stock’s 50-day moving average price is GBX 3.88 and its 200-day moving average price is GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Activity at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction that occurred on Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). 14.02% of the stock is owned by insiders.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

See Also